Trial site
Illinois Cancer Care
- 16running trials
- 12closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Lung cancer14 trials
- Childhood cancers3 trials
- Colorectal cancer2 trials
- Hodgkin lymphoma2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Mantle cell lymphoma1 trial
- and 6 more
- Phase
- Phase 314 trials
- Phase 25 trials
- Phase 1/21 trial
- Status
- Completed9 trials
- Active, not recruiting8 trials
- Recruiting8 trials
- Terminated3 trials
- Lead sponsor
- Hoffmann-La Roche7 trials
- Tempus AI3 trials
- Bristol-Myers Squibb2 trials
- Celgene2 trials
- Pfizer2 trials
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Active, not recruiting
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer5 recruiting
- Colorectal cancer1 recruiting
- Head and neck cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Umbrella Study for Analysis of Data Related to Patients With Cancer
Completed
Completed
Completed
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026